Growth Metrics

CareDx (CDNA) Cost of Revenue (2016 - 2026)

CareDx's Cost of Revenue history spans 14 years, with the latest figure at $30.4 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 32.11% to $30.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $110.0 million, a 29.23% increase, with the full-year FY2025 number at $102.6 million, up 25.21% from a year prior.
  • Cost of Revenue hit $30.4 million in Q1 2026 for CareDx, down from $30.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for CDNA hit a ceiling of $30.9 million in Q4 2025 and a floor of $18.5 million in Q3 2023.
  • Historically, Cost of Revenue has averaged $23.2 million across 5 years, with a median of $23.0 million in 2025.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 49.81% in 2022 and later decreased 19.74% in 2023.
  • Tracing CDNA's Cost of Revenue over 5 years: stood at $23.7 million in 2022, then fell by 12.43% to $20.7 million in 2023, then grew by 2.96% to $21.3 million in 2024, then skyrocketed by 44.9% to $30.9 million in 2025, then dropped by 1.78% to $30.4 million in 2026.
  • Business Quant data shows Cost of Revenue for CDNA at $30.4 million in Q1 2026, $30.9 million in Q4 2025, and $24.4 million in Q3 2025.